Gándara M V, de Vega D S, Escriú N, Olmedilla C, Pérez-Mencia M T, Zueras R, López A
Servicio de Anestesiología y Reanimación, Hospital General de Móstoles, Madrid.
Rev Esp Anestesiol Reanim. 1997 May;44(5):177-81.
To analyze the repercussions of CO2 pneumoperitoneum on the ventilation of healthy patients undergoing laparoscopic cholecystectomy; to assess the influence of anesthetic technique and determine whether duration of procedure or CO2 volume are relevant factors.
Prospective study of 132 patients undergoing laparoscopic cholecystectomy. The patients were selected based on disease and level of anesthetic risk and then randomly assigned to three groups to receive anesthesia with oxygen/nitrous oxide (group I), isoflurane in O2 and air (FIO2 0.4) (group II) or propofol in continuous infusion with O2 and air (FIO2 0.4) (group III). Analgesia and muscle relaxation were the same in all groups. Monitoring included blood pressure (BP), heart rate (HR), electrocardiography (ECG), central venous pressure (CVP), capnography (PETco2), pulse oximetry (SaO2), peak airways pressure (PAP), FIO2, intra-abdominal pressure (IAP), volume in insufflated CO2 and serial gasometry. Readings were taken before pneumoperitoneum after 20 minutes and every 30 minutes until end of surgery. After surgery parameters were recorded four more times at intervals of 30 minutes.
The groups were homogeneous. pneumoperitoneum caused a decrease in PaO2 (p < 0.001) and SaO2 and increases in PaCO2, PETco2 and CVP, although levels later stabilized. No relation was found between duration of pneumoperitoneum or CO2 volumen and any of the changes observed. Group I had the lowest mean PaO2 before pneumoperitoneum and 60 minutes later (p < 0.05). Group II had the smallest increase in PaCO2, although the difference was non significant.
CO2 pneumoperitoneum caused ventilatory changes dependent on uptake and increased abdominal pressure. The duration and volume of CO2 used did not influence the parameters studied. The clinical significance of these changes is slight in the healthy patient. The anesthetic agents used did not have substantial effects.
分析二氧化碳气腹对接受腹腔镜胆囊切除术的健康患者通气功能的影响;评估麻醉技术的作用,并确定手术持续时间或二氧化碳量是否为相关因素。
对132例接受腹腔镜胆囊切除术的患者进行前瞻性研究。根据疾病和麻醉风险水平选择患者,然后随机分为三组,分别接受氧气/氧化亚氮麻醉(第一组)、氧气和空气(FIO2 0.4)中的异氟烷麻醉(第二组)或氧气和空气(FIO2 0.4)持续输注丙泊酚麻醉(第三组)。所有组的镇痛和肌肉松弛情况相同。监测项目包括血压(BP)、心率(HR)、心电图(ECG)、中心静脉压(CVP)、二氧化碳监测(PETco2)、脉搏血氧饱和度(SaO2)、气道峰压(PAP)、FIO2、腹内压(IAP)、注入二氧化碳量和系列气体分析。在气腹前、气腹后20分钟以及每隔30分钟直至手术结束时进行读数。术后每隔30分钟再记录参数四次。
各组情况相似。气腹导致PaO2降低(p < 0.001)和SaO2降低,PaCO2、PETco2和CVP升高,不过随后水平趋于稳定。未发现气腹持续时间或二氧化碳量与所观察到的任何变化之间存在关联。第一组在气腹前及60分钟后平均PaO2最低(p < 0.05)。第二组PaCO2升高幅度最小,尽管差异不显著。
二氧化碳气腹引起的通气变化取决于气体摄取和腹压升高。所用二氧化碳的持续时间和量并未影响所研究的参数。这些变化在健康患者中的临床意义较小。所用麻醉药物没有实质性影响。